Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B

Oral Oncology

Volumn 46, Issue 4, 2010, Pages 263-270

  Qi, Guangying ^a   Kudo, Yasusei ^a   Ando, Toshinori ^a   Tsunematsu, Takaaki ^a   Shimizu, Natsumi ^a   Siriwardena, Samadarani B S M ^a   Yoshida, Maki ^a   Keikhaee, Mohammad Reza ^a   Ogawa, Ikuko ^b   Takata, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aurora B; Chromosomal passenger complex; Head and neck cancer; Survivin

Indexed keywords

AURORA B KINASE; KI 67 ANTIGEN; SURVIVIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER;

EID: 77949571449     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.01.004     Document Type: Article

References (31)

1. Uren A.G., Pakusch M., Hawkins C.J., Puls K.L., and Vaux D.L. Cloning and expression of apoptosis inhibition protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93 10 (1996) 4974-4978
2. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med 3 8 (1997) 917-921
3. Chiou S.K., Jones M.K., and Tarnawski A.S. Survivin an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9 4 (2003) 125-129
4. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., and Tanigawa N. Expression of Survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6 1 (2000) 127-134
5. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., Briere J., et al. Prognostic significance of Survivin expression in diffuse large B-cell lymphomas. Blood 96 5 (2000) 1921-1925
6. Wakana Y., Kasuya K., Katayanagi S., et al. Oncol Rep 9 6 (2002) 1213-1218
7. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., and Tanigawa N. Inhibition of apoptosis by Survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58 22 (1998) 5071-5074
8. Sui L., Dong Y., Ohno M., Watanabe Y., Sugimoto K., and Tokuda M. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumours. Int J Oncol 21 2 (2002) 315-320
9. Artieri D.C. The case for Survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 18 6 (2006) 609-615
10. Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F., Honda R., et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol 166 2 (2004) 179-191
11. Lens S.M., Vader G., and Medema R.H. The case for Survivin as mitotic regulator. Curr Opin Cell Biol 18 6 (2006) 616-622
12. Bolton M.A., Lan W., Powers S.E., McCleland M.L., Kuang J., and Stukenberg P.T. Aurora B kinase exists in a complex with Survivin and INCENP and its kinase activity is stimulated by Survivin binding and phosphorylation. Mol Biol Cell 13 9 (2002) 3064-3077
13. Honda R., Korner R., and Nigg E.A. Exploring the functional interactions between Aurora B, INCENP, and Survivin in mitosis. Mol Biol Cell 14 8 (2003) 3325-3341
14. Adams R.R., Eckley D.M., Vagnarelli P., Wheatley S.P., Gerloff D.L., Mackay A.M., et al. Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosome 110 2 (2001) 65-74
15. Beardmore V.A., Ahonen L.J., Gorbsky G.J., and Kallio M.J. Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J Cell Sci 117 18 (2004) 4033-4042
16. Qi G., Ogawa I., Kudo Y., Miyauchi M., Siriwardena B.S., Shimamoto F., et al. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch 450 3 (2007) 297-302
17. Stauber R.H., Mann W., and Knauer S.K. Nuclear and cytoplasmic Survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67 13 (2007) 5999-6002
18. Lin C.Y., Hung H.C., Kuo R.C., Chiang C.P., and Kuo M.Y. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 6 (2005) 645-654
19. Jane C., Nerurkar A.V., Shirsat N.V., Deshpande R.B., Amrapurkar A.D., and Karjodkar F.R. Increased Survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 35 10 (2006) 595-601
20. Li F., Yang J., Ramnath N., Javle M.M., and Tan D. Nuclear or cytoplasmic expression of Survivin: what is the significance?. Int J Cancer 114 4 (2005) 509-512
21. Engels K., Knauer S., Metzler D., Simf C., Struschka O., Bier C., et al. Dynamic intracellular Survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early rognostic marker. J Pathol 211 5 (2007) 532-540
22. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 6836 (2001) 494-498
23. Knauer S.K., Bier C., Habtemichael N., and Stauber R.H. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 7 12 (2006) 1259-1265
24. Colnaghi R., Connell C.M., Barrett R.M., and Wheatley S.P. Separating the anti-apoptotic and mitotic roles of Survivin. J Biol Chem 281 44 (2006) 33450-33456
25. Marioni G., Bedogni A., Giacomelli L., Ferraro S.M., Bertolin A., Facco E., et al. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Otolaryngol 125 11 (2005) 1218-1223
26. Grabowski P., Kuhnel T., Muhr-Wilkenshoff F., Heine B., Stein H., Höpfner M., et al. Prognostic value of nuclear Survivin expression in oesophageal squamous cell carcinoma. Br J cancer 88 1 (2003) 115-119
27. Okada E., Murai Y., Matsui K., Isizawa S., Cheng C., Masuda M., et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163 1 (2001) 109-116
28. Tonini G., Vincenzi B., Santini D., Scarpa S., Vasaturo T., Malacrino C., et al. Nuclear and cytoplasmic expression of Survivin in 67 surgically resected pancreatic cancer patients. Br J cancer 92 12 (2005) 2225-2232
29. Tatsuka M., Katayama H., Ota T., Tanaka T., Odashima S., Suzuki F., et al. Multinuclearity and increased ploidy caused by overexpression of the Aurora B and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 58 21 (1998) 4811-4816
30. Kanda A., Kawai H., Suto S., Kitajima S., Sato S., Takata T., et al. Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation. Oncogene 24 49 (2006) 7266-7272
31. Temme A., Rieber E.P., Schmitz M., Morgenroth A., Weigle B., Rieger M.A., et al. Increased p21(ras) activity in human fibroblasts transduced with Survivin enhances cell proliferation. Biochem Biophys Res Commun 327 3 (2005) 765-773